Metabolic Dysfunction-associated Fatty Liver Disease Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting metabolic dysfunction-associated fatty liver disease clinical trials across 3 countries. Studies span Not Applicable, Phase 3. Top locations include Chongqing, Chongqing Municipality, China, Hangzhou, Zhejiang, China, Guangzhou, Guangdong, China. Updated daily from ClinicalTrials.gov.


Metabolic Dysfunction-associated Fatty Liver Disease Trials at a Glance

7 actively recruiting trials for metabolic dysfunction-associated fatty liver disease are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Chongqing, Hangzhou, and Guangzhou. Lead sponsors running metabolic dysfunction-associated fatty liver disease studies include Chongqing Medical University, Innovent Biologics (Suzhou) Co. Ltd., and Phenomen Pharma.

Browse metabolic dysfunction-associated fatty liver disease trials by phase

Treatments under study

About Metabolic Dysfunction-associated Fatty Liver Disease Clinical Trials

Looking for clinical trials for Metabolic Dysfunction-associated Fatty Liver Disease? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metabolic Dysfunction-associated Fatty Liver Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metabolic Dysfunction-associated Fatty Liver Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Type 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated SteatohepatitisMetabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School10,000 enrolled22 locationsNCT07632677
Recruiting
Not Applicable

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Fatty Liver DiseaseHepatomegalyFatty Liver+5 more
Phenomen Pharma90 enrolled1 locationNCT07068191
Recruiting
Phase 3

A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

OverweightMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent Biologics (Suzhou) Co. Ltd.470 enrolled1 locationNCT06884293
Recruiting

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Inflammatory Bowel Disease (IBD)Metabolic Dysfunction-associated Fatty Liver Disease
Shanghai East Hospital337 enrolled1 locationNCT06939569
Recruiting

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Liver FibrosisHepatic SteatosisMetabolic Dysfunction-associated Fatty Liver Disease
Chongqing Medical University7,000 enrolled1 locationNCT05974904
Recruiting

Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease

Thyroid DysfunctionMetabolic Dysfunction-associated Fatty Liver Disease
Tanta University150 enrolled1 locationNCT06739330
Recruiting

Positive Association of US-FLI With the Severity of CAD

UltrasonographyMetabolic Dysfunction-associated Fatty Liver DiseaseCoronary Artery Disease of Significant Bypass Graft+1 more
Chongqing Medical University190 enrolled1 locationNCT06541132